Skip to main content

Market Overview

22 Healthcare Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) shares surged 83.4% to $18.45 during Monday's pre-market session. The market cap stands at $745.3 million. According to the most recent rating by Credit Suisse, on July 10, the current rating is at Neutral.
  • Champions Oncology, Inc. (NASDAQ: CSBR) shares moved upwards by 24.0% to $7.50. According to the most recent rating by Janney Capital, on July 24, the current rating is at Neutral.
  • Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) stock moved upwards by 13.4% to $1.35.
  • vTv Therapeutics, Inc. (NASDAQ: VTVT) stock moved upwards by 7.4% to $1.75.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stock rose 5.1% to $31.47. The most recent rating by B. Riley, on August 19, is at Buy, with a price target of $46.00.
  • NeuroMetrix, Inc. (NASDAQ: NURO) stock rose 4.1% to $0.46. The market cap stands at $3.5 million.
  • Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) stock rose 3.5% to $11.41. The market value of their outstanding shares is at $515.2 million. The most recent rating by JP Morgan, on July 23, is at Overweight, with a price target of $16.00.
  • Tocagen, Inc. (NASDAQ: TOCA) shares increased by 2.9% to $1.06. The market cap seems to be at $219.2 million. The most recent rating by Chardan Capital, on September 13, is at Neutral, with a price target of $1.00.
  • Arqule, Inc. (NASDAQ: ARQL) shares surged 2.9% to $8.20. The market cap seems to be at $143.7 million.
  • Moleculin Biotech, Inc. (NASDAQ: MBRX) stock rose 2.5% to $1.25.

 

Losers

  • Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) stock declined 7.4% to $0.30 during Monday's pre-market session. The market value of their outstanding shares is at $3.5 million.
  • Motif Bio, Inc. (NASDAQ: MTFB) shares plummeted 5.5% to $0.69. The market cap seems to be at $11.5 million.
  • Jaguar Health, Inc. (NASDAQ: JAGX) stock fell 5.3% to $1.26. The market cap stands at $9.3 million. The most recent rating by Ladenburg Thalmann, on September 12, is at Buy, with a price target of $5.00.
  • Aurora Cannabis, Inc. (NYSE: ACB) stock plummeted 5.2% to $5.64. The market cap seems to be at $6.3 billion. The most recent rating by Stifel, on September 16, is at Sell, with a price target of $5.00.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) stock decreased by 4.2% to $2.07. The market cap stands at $42.3 million.
  • Mallinckrodt, Inc. (NYSE: MNK) stock plummeted 3.8% to $3.17. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) stock fell 3.3% to $1.18. The market value of their outstanding shares is at $14.6 million.
  • Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) stock decreased by 2.9% to $6.40. The most recent rating by Oppenheimer, on September 10, is at Outperform, with a price target of $14.00.
  • Digirad, Inc. (NASDAQ: DRAD) shares plummeted 2.6% to $5.50. The market value of their outstanding shares is at $40.1 million.
  • Endo International, Inc. (NASDAQ: ENDP) stock declined 2.6% to $3.78. The market value of their outstanding shares is at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
  • Advaxis, Inc. (NASDAQ: ADXS) shares fell 2.5% to $0.30. The market value of their outstanding shares is at $77.0 million.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares decreased by 2.4% to $2.81. The market cap stands at $209.3 million. According to the most recent rating by Janney Capital, on September 12, the current rating is at Buy.
 

Related Articles (ADXS + ACB)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com